U.S. Life Sciences Stock News

Ever wondered if Arm Holdings’ recent hype actually makes it a good buy? Let’s dig beneath the headlines and find out what the numbers are telling us about the stock’s true value. Arm Holdings’ share price has shown serious action lately, climbing 12.9% over the past month and now up 32.5% year-to-date, even after a slight dip of 0.5% in the last week. Some of those moves are thanks to reports of fresh partnerships and tech advancements, as Arm pushes into new markets amid growing demand for...

Federal Home Loan Mortgage (FMCC) reported that it remains unprofitable, with losses deepening at a steep 48.5% annual pace over the past five years. Revenue is projected to grow at just 2.7% annually, trailing the broader US market’s 10.3% average. Despite continued losses, FMCC’s shares trade at $9.53, notably below the estimated fair value of $54.14. Its low Price-to-Sales Ratio suggests potential value for investors willing to weigh the ongoing operational challenges against valuation...

MasTec (MTZ) posted a striking 272.8% earnings growth over the past year, reversing a five-year average slide of 23.3% per year. Net profit margins expanded to 2.4%, up from last year’s 0.7%. Annual revenues are projected to grow at 8.4%, trailing the broader US market’s 10.3% pace. With earnings expected to outpace the market at 22.7% growth per year for the next three years, investors are eyeing this rapid shift in profitability and the ongoing margin improvement as the biggest story from...

Comcast recently reported its third quarter 2025 financial results, confirming a quarterly dividend of US$0.33 per share and announcing the promotion of Steve Croney to CEO of its Connectivity & Platforms division starting January 2026. The combined impact of these operational updates and leadership changes offers insights into how Comcast is evolving its business in the face of industry headwinds and shifting consumer preferences. We'll look at how the new Connectivity & Platforms CEO...

Colgate-Palmolive (CL) reported 2.4% earnings growth over the past year, beating its five-year average growth rate of 2.2% per year. Net profit margin edged up to 14.5% from 14.2% last year, and earnings are projected to grow at 6.8% annually, with revenue expected to climb by 3.3% per year. Both rates trail the broader US market’s growth forecasts. Investors are balancing steady profit and revenue momentum, an appealing dividend, and modest financial risks as they weigh the stock’s...

Werner Enterprises (WERN) reported a net profit margin of 0.8%, down from last year’s 1.5%, and earnings have dropped substantially, with a 29.2% annual decline over the past five years. The company’s price-to-earnings ratio stands at 62x, well above the US transportation industry average of 25.9x. The current share price is $26.20, trading above its estimated fair value of $19.49. Despite recent margin pressures and a one-off gain of $29.7 million distorting the bottom line, investors may...

Tiptree (TIPT) delivered an impressive 81.4% annual earnings growth over the past twelve months, with net profit margins rising to 2.8% compared to last year’s 1.6%. While the current share price sits at $17.71, well above the $12.24 analyst fair value estimate, the company’s consistent profitability and margin expansion over the last five years are clear positives for investors. See our full analysis for Tiptree. Next up, we’ll see how these results stack up against prevailing narratives,...

Ultragenyx Pharmaceutical (RARE) announced the first patient has been dosed in its Aurora study evaluating GTX-102 for Angelman syndrome, opening up research to a broader group of patients than before. This milestone signals meaningful progress in Ultragenyx's clinical pipeline. The Aurora study will include participants across a wider age spectrum and genetic profiles not addressed in the earlier Phase 3 Aspire trial. Investors eyeing rare disease pipelines may find the widened scope...

T. Rowe Price Group (TROW) posted a 4.7% increase in earnings over the past year, reversing the average annual decline of 9.1% seen over the prior five years. The company's net profit margin inched up to 28% from last year’s 27.9%. Looking ahead, earnings are projected to grow at 8.9% per year, trailing the broader US market's 15.9% forecasted rate. Investors are weighing TROW’s attractive valuation, strong relative value, and stable margins against concerns about dividend sustainability. See...

Silicon Motion Technology (SIMO) posted net profit margins of 10.2%, just above last year’s 10.1%, but its earnings have declined at an average rate of 12.4% per year over the past five years. Despite this, analysts expect earnings to rebound strongly with annual growth of 31.18%, outpacing both sector peers and the overall US market. Investors are now weighing this upbeat profit forecast alongside an expected 13.9% yearly revenue growth and recent margin stability as they consider how much...

Heartland Express (HTLD) remains unprofitable, with losses compounding at a rapid 44% annual rate over the past five years. Despite forecasts calling for revenue to grow by 5.2% per year, the company’s growth trails the broader US market’s 10.3% annual pace. This leaves investors to scrutinize both the depth of its losses and the tepid outlook for improvement. See our full analysis for Heartland Express. Next, we’ll see how this set of earnings results stacks up against the most widely...

Envista Holdings (NVST) shares saw a small move today, with no major headlines or announcements setting the pace. With this quiet backdrop, some investors may be re-evaluating the stock's longer-term performance and current value. See our latest analysis for Envista Holdings. Envista Holdings’ share price has edged up recently, now sitting at $20.35. This still leaves the company with a modest year-to-date gain and a 1-year total shareholder return of -2.8%. Momentum has yet to meaningfully...

Strattec Security (STRT) turned heads this earnings season with standout growth numbers. The company has achieved profitability over the last five years, boasting an impressive 17.3% annual earnings growth rate, and its net profit margin climbed to 4.1% from 2.9% a year earlier. Crucially, last year’s earnings surged by 48.3%, well outpacing the multi-year average. The 20.2% annual earnings growth forecast puts it above the US market’s 15.9% expectation. While revenue is projected to rise at...

Alerus Financial (ALRS) reported a sharp turnaround in profitability, with net profit margins climbing to 15.3% from just 4.3% a year earlier. EPS growth was eye-catching at 442.1% compared to last year, but this accelerates off a five-year run rate where earnings have fallen on average by 23.7% per year. Despite the bounce, revenue is forecast to grow only 3.5% annually, which is well behind the broader US market at 10.3%. The company’s share price remains below estimated fair value,...

SB Financial Group (SBFG) posted a net profit margin of 19.5%, down from last year’s 21.5%, while earnings have fallen an average of 11.2% per year over the past five years. Most recently, the company experienced another year of negative earnings growth, making further year-to-year acceleration comparisons less meaningful. With high-quality earnings but profit and margin pressures still in play, investors are left weighing value and dividends against a lack of growth in the foreseeable...

Stagwell (STGW) has rolled out Agent Cloud, a new platform designed to give marketers unified access to multiple AI models and marketing assistants. The platform streamlines how teams manage their digital campaigns. See our latest analysis for Stagwell. Stagwell’s Agent Cloud launch may help shift sentiment after a difficult year. Its latest share price of $4.75 reflects a year-to-date decline of 26.6% and a one-year total shareholder return of -26.9%. While short-term momentum remains muted,...

Amneal Pharmaceuticals (AMRX) has posted a standout earnings outlook, with net income projected to grow at a rapid 80.1% per year for the next three years, far surpassing the US market average of 15.9%. While the company’s revenue is expected to grow at a slower pace of 7.7% per year, recent filings confirm its return to profitability and an improvement in net profit margins compared to the previous year. Amid these results, Amneal’s shares currently trade at $10.82, notably below the...

Alight (ALIT) is stepping up its digital game as it announces an expanded partnership with IBM to bring advanced AI capabilities into its employee benefits offerings. This follows a new deal with MetLife to enhance retirement solutions, as well as the launch of an AI benefits assistant. See our latest analysis for Alight. Despite Alight’s recent flurry of AI partnerships and digital launches, the market has remained sharply skeptical, with a 1-year total shareholder return of -56.4% and the...

Coca-Cola Consolidated, Inc. reported strong third-quarter 2025 results, with net sales rising to US$1.89 billion and net income reaching US$142.33 million, both up from the prior year. Alongside improved operating margins, the company completed a sizeable share repurchase program and continued returning significant capital to shareholders through buybacks and dividends. We’ll examine how the company’s earnings growth and capital return initiatives shape its investment narrative going...

W.W. Grainger (GWW) finished the period with a net profit margin of 11%, a slight uptick from last year’s 10.9%. Over the past five years, the company’s earnings have grown at an average annual rate of 20.9%, though this most recent year saw growth slow to 5.7%. Looking ahead, projected annual earnings growth of 8.7% and revenue growth of 6.3% both trail the broader U.S. market rates. Shares trade at a Price-to-Earnings ratio of 24.4x, which is above peer and industry averages, while...

Digimarc (DMRC) remains unprofitable and is forecast to stay in the red for at least the next three years. The company has managed to trim its losses by about 1.6% per year over the past five years. Revenue is expected to grow at a modest 5.6% per year, which trails the broader US market’s growth rate of 10.3% per year. Investors will keep a close eye on whether Digimarc can turn incremental improvements into long-term strength, especially as its valuation stays elevated at a Price-to-Sales...

Redwire (NYSE:RDW) is making moves in the defense sector after its subsidiary, Edge Autonomy, signed a Memorandum of Understanding with UXV Technologies. The partnership focuses on uncrewed aerial systems and European defense collaboration. See our latest analysis for Redwire. Redwire’s shares have had a turbulent ride. The latest defense partnership news arrives after a 53.8% year-to-date decline in the share price, even though the three-year total shareholder return stands at an...

M/I Homes reported earnings for the third quarter and nine months ended September 30, 2025, showing year-over-year declines in both revenue and net income alongside the completion of a significant share buyback program. The company’s persistent headwinds from high mortgage rates and affordability issues have resulted in a fourth consecutive quarter of missed earnings, signaling ongoing challenges in the housing market. We’ll explore how weaker-than-expected quarterly results and...

SS Innovations International recently announced strong third-quarter 2025 results, with revenue rising to US$12.83 million from US$4.39 million a year earlier, alongside a 350% increase in SSi Mantra surgical robotic system installations. The company is actively expanding into new international markets, having gained regulatory approvals in seven countries and working towards U.S. FDA and EU CE mark submissions. We'll explore how SS Innovations International's rapid operational expansion and...